BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 22496590)

  • 1. Loss of XLαs (extra-large αs) imprinting results in early postnatal hypoglycemia and lethality in a mouse model of pseudohypoparathyroidism Ib.
    Fernández-Rebollo E; Maeda A; Reyes M; Turan S; Fröhlich LF; Plagge A; Kelsey G; Jüppner H; Bastepe M
    Proc Natl Acad Sci U S A; 2012 Apr; 109(17):6638-43. PubMed ID: 22496590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted deletion of the Nesp55 DMR defines another Gnas imprinting control region and provides a mouse model of autosomal dominant PHP-Ib.
    Fröhlich LF; Mrakovcic M; Steinborn R; Chung UI; Bastepe M; Jüppner H
    Proc Natl Acad Sci U S A; 2010 May; 107(20):9275-80. PubMed ID: 20427744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of the noncoding GNAS antisense transcript causes pseudohypoparathyroidism type Ib and biparental defects of GNAS methylation in cis.
    Chillambhi S; Turan S; Hwang DY; Chen HC; Jüppner H; Bastepe M
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3993-4002. PubMed ID: 20444925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The GNAS locus and pseudohypoparathyroidism.
    Bastepe M
    Adv Exp Med Biol; 2008; 626():27-40. PubMed ID: 18372789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new deletion ablating NESP55 causes loss of maternal imprint of A/B GNAS and autosomal dominant pseudohypoparathyroidism type Ib.
    Richard N; Abeguilé G; Coudray N; Mittre H; Gruchy N; Andrieux J; Cathebras P; Kottler ML
    J Clin Endocrinol Metab; 2012 May; 97(5):E863-7. PubMed ID: 22378814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autosomal dominant pseudohypoparathyroidism type Ib is associated with a heterozygous microdeletion that likely disrupts a putative imprinting control element of GNAS.
    Bastepe M; Fröhlich LF; Hendy GN; Indridason OS; Josse RG; Koshiyama H; Körkkö J; Nakamoto JM; Rosenbloom AL; Slyper AH; Sugimoto T; Tsatsoulis A; Crawford JD; Jüppner H
    J Clin Invest; 2003 Oct; 112(8):1255-63. PubMed ID: 14561710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GNAS epigenetic defects and pseudohypoparathyroidism: time for a new classification?
    Mantovani G; Elli FM; Spada A
    Horm Metab Res; 2012 Sep; 44(10):716-23. PubMed ID: 22674477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct patterns of abnormal GNAS imprinting in familial and sporadic pseudohypoparathyroidism type IB.
    Liu J; Nealon JG; Weinstein LS
    Hum Mol Genet; 2005 Jan; 14(1):95-102. PubMed ID: 15537666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of Gnas epigenetic changes and pseudohypoparathyroidism type Ib in mice with targeted disruption of syntaxin-16.
    Fröhlich LF; Bastepe M; Ozturk D; Abu-Zahra H; Jüppner H
    Endocrinology; 2007 Jun; 148(6):2925-35. PubMed ID: 17317779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mouse model of albright hereditary osteodystrophy generated by targeted disruption of exon 1 of the Gnas gene.
    Germain-Lee EL; Schwindinger W; Crane JL; Zewdu R; Zweifel LS; Wand G; Huso DL; Saji M; Ringel MD; Levine MA
    Endocrinology; 2005 Nov; 146(11):4697-709. PubMed ID: 16099856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autosomal-dominant pseudohypoparathyroidism type Ib is caused by different microdeletions within or upstream of the GNAS locus.
    Jüppner H; Linglart A; Fröhlich LF; Bastepe M
    Ann N Y Acad Sci; 2006 Apr; 1068():250-5. PubMed ID: 16831926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel STX16 deletion in autosomal dominant pseudohypoparathyroidism type Ib redefines the boundaries of a cis-acting imprinting control element of GNAS.
    Linglart A; Gensure RC; Olney RC; Jüppner H; Bastepe M
    Am J Hum Genet; 2005 May; 76(5):804-14. PubMed ID: 15800843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial Pseudohypoparathyroidism Type IB Associated with an SVA Retrotransposon Insertion in the GNAS Locus.
    Kawashima S; Yuno A; Sano S; Nakamura A; Ishiwata K; Kawasaki T; Hosomichi K; Nakabayashi K; Akutsu H; Saitsu H; Fukami M; Usui T; Ogata T; Kagami M
    J Bone Miner Res; 2022 Oct; 37(10):1850-1859. PubMed ID: 35859320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Multiple Families With Single Individuals Affected by Pseudohypoparathyroidism Type Ib (PHP1B) Reveals Only One Novel Maternally Inherited GNAS Deletion.
    Takatani R; Molinaro A; Grigelioniene G; Tafaj O; Watanabe T; Reyes M; Sharma A; Singhal V; Raymond FL; Linglart A; Jüppner H
    J Bone Miner Res; 2016 Apr; 31(4):796-805. PubMed ID: 26479409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of the NESP55 differentially methylated region causes loss of maternal GNAS imprints and pseudohypoparathyroidism type Ib.
    Bastepe M; Fröhlich LF; Linglart A; Abu-Zahra HS; Tojo K; Ward LM; Jüppner H
    Nat Genet; 2005 Jan; 37(1):25-7. PubMed ID: 15592469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and epigenetic states of the GNAS complex in pseudohypoparathyroidism type Ib using methylation-specific multiplex ligation-dependent probe amplification assay.
    Yuno A; Usui T; Yambe Y; Higashi K; Ugi S; Shinoda J; Mashio Y; Shimatsu A
    Eur J Endocrinol; 2013 Feb; 168(2):169-75. PubMed ID: 23132697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Familial PHP1B Variant With Incomplete Loss of Methylation at GNAS-A/B and Enhanced Methylation at GNAS-AS2.
    Hanna P; Francou B; Delemer B; Jüppner H; Linglart A
    J Clin Endocrinol Metab; 2021 Aug; 106(9):2779-2787. PubMed ID: 33677588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PCR-based analysis of differentially methylated regions of GNAS enables convenient diagnostic testing of pseudohypoparathyroidism type Ib.
    Weinhaeusel A; Thiele S; Hofner M; Hiort O; Noehammer C
    Clin Chem; 2008 Sep; 54(9):1537-45. PubMed ID: 18617581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complex Genomic Rearrangement Within the GNAS Region Associated With Familial Pseudohypoparathyroidism Type 1b.
    Nakamura A; Hamaguchi E; Horikawa R; Nishimura Y; Matsubara K; Sano S; Nagasaki K; Matsubara Y; Umezawa A; Tajima T; Ogata T; Kagami M; Okamura K; Fukami M
    J Clin Endocrinol Metab; 2016 Jul; 101(7):2623-7. PubMed ID: 27253667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in GNAS epigenetic research of pseudohypoparathyroidism.
    Izzi B; Van Geet C; Freson K
    Curr Mol Med; 2012 Jun; 12(5):566-73. PubMed ID: 22300135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.